This Perspective suggests a characterization cascade for nanoparticle-based vaccines that takes into consideration the complexity of the materials and of their immunomodulatory responses, providing a roadmap for the preclinical validation of potential vaccine candidates.
- Giuditta Guerrini
- Davide Magrì
- Luigi Calzolai
